Related Experiment Video
Updated: Oct 18, 2025
05:11
Multimodal 3D Printing of Phantoms to Simulate Biological Tissue
Published on: January 11, 2020
7.7K
3D Printing Scaffold Vaccine for Antitumor Immunity
Yue Zhang1, Jialu Xu1, Ziying Fei1
1Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.
Advanced Materials (Deerfield Beach, Fla.)
|October 3, 2021
Summary
3D printed scaffolds loaded with immunoregulators enhance cancer immunotherapy by mimicking lymphoid organs to boost immune cell activity. This 3D printing scaffold vaccine strategy shows promise for future cancer vaccine therapy and preventing metastasis.
Area of Science:
- Biomaterials Science
- Immunology
- Cancer Research
Background:
- Cancer immunotherapy has garnered significant attention for its therapeutic potential.
- Developing effective cancer vaccines remains a critical challenge in oncology.
- Traditional vaccine delivery methods often face limitations in efficacy and personalization.
Purpose of the Study:
- To develop and evaluate 3D printed scaffolds loaded with immunoregulators for enhanced cancer immunotherapy.
- To investigate the potential of these scaffolds in mimicking natural lymphoid structures.
- To assess the efficacy of personalized 3D printed scaffold vaccines in preventing tumor recurrence and metastasis.
Main Methods:
- Fabrication of porous 3D scaffolds using 3D printing technology.
- Loading scaffolds with immunoregulators to modulate the immune response.
- In vitro and in vivo evaluation of scaffold-induced immune cell recruitment and activation.
- Combination therapy with immune checkpoint blockade.
- Demonstration of personalized scaffold filling of tumor sites post-surgery.
Main Results:
- 3D printed scaffolds successfully mimicked the function of lymphoid organs by recruiting immune cells and forming artificial tertiary lymphoid structures.
- Scaffolds enhanced both humoral and cellular immune responses, leading to efficient anticancer immunity.
- Combination therapy with immune checkpoint blockade significantly inhibited tumor growth.
- Personalized scaffold vaccines demonstrated potential in preventing postsurgical cancer metastasis.
Conclusions:
- 3D printed scaffolds loaded with immunoregulators represent a promising platform for cancer vaccine development.
- The ability to create artificial tertiary lymphoid structures offers a novel approach to enhance anti-tumor immunity.
- Personalized 3D printed scaffold vaccines hold potential for preventing cancer recurrence and metastasis, offering a future strategy for cancer therapy.
